Comparative Study of Lung Bioavailability of HFA-Seretide Via Current Spacer Devices in Healthy Volunteers

Condition:   Asthma
Interventions:   Drug: Seretide 250(8puffs) via Evohaler actuator;   Drug: Seretide 250 (8 puffs)/placebo via Volumatic spacer;   Drug: Seretide 250/placebo 8 puffs via Aerochamber Plus spacer;   Drug: Seretide 250/placebo via Synchro-Breathe
Sponsor:   University of Dundee
Completed – verified December 2009

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days

A Phase 1 Study of CNTO 3157 in Healthy Volunteers and Patients With Asthma

Condition:   Asthma
Interventions:   Biological: CNTO 3157 or placebo;   Biological: CNTO 3157 or placebo;   Biological: CNTO 3157 or placebo;   Biological: CNTO 3157 or placebo;   Biological: CNTO 3157 or placebo;   Biological: CNTO 3157 or placebo;   Biological: CNTO 3157 or placebo;   Biological: CNTO 3157 or placebo
Sponsor:   Centocor, Inc.
Recruiting – verified September 2010

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days

Pfizer’s Spiriva brings hope to asthma patients – Healthy Living


Healthy Living

Pfizer's Spiriva brings hope to asthma patients
Healthy Living
Asthma is a disease that poses difficulty in your ability to breathe. I have seen many members of my family suffer from asthma, as a genetic disorder.
Spiriva as good as Serevent in asthma studyThe Associated Press
Early Trial Suggests COPD Drug Might Help Some AsthmaticsBusinessWeek
Drug helps treatment of resistant asthmaUPI.com
Reuters India –Los Angeles Times –One News Page
all 244 news articles »

View full post on asthma – Google News